GoodRx Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
697
- Stock Symbol
-
GDRX
- Investments
-
10
- Share Price
-
$3.51
- (As of Thursday Closing)
GoodRx General Information
Description
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Contact Information
Website
www.goodrx.comCorporate Office
- 2701 Olympic Boulevard
- West Building Suite 200
- Santa Monica, CA 90404
- United States
Corporate Office
- 2701 Olympic Boulevard
- West Building Suite 200
- Santa Monica, CA 90404
- United States
GoodRx Stock Performance
As of 12-Nov-2026, GoodRx’s stock price is $3.51. Its current market cap is $1.2B with 341M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.51 | $3.65 | $1.77 - $3.89 | $1.2B | 341M | 1.16M | $0.05 |
GoodRx Financials Summary
As of 30-Jun-2026, GoodRx has a trailing 12-month revenue of $785M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,281,026 | 1,191,469 | 1,893,101 | 2,637,658 |
| Revenue | 785,230 | 796,853 | 792,324 | 750,265 |
| EBITDA | 164,231 | 173,428 | 130,647 | 76,653 |
| Net Income | 16,249 | 30,439 | 16,390 | (8,868) |
| Total Assets | 2,342,928 | 1,404,058 | 1,388,067 | 1,588,800 |
| Total Debt | 538,950 | 542,806 | 543,387 | 711,070 |
GoodRx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GoodRx Comparisons
Industry
Financing
Details
GoodRx Competitors (7)
One of GoodRx’s 7 competitors is RxSense, a Private Equity-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RxSense | Private Equity-Backed | Boston, MA | ||||
| mPharma | Venture Capital-Backed | Accra, Ghana | ||||
| Blink Health | Private Equity-Backed | New York, NY | ||||
| OptumRx | Corporate Backed or Acquired | Irvine, CA | ||||
| Teladoc Health | Formerly VC-backed | New York, NY |
GoodRx Patents
GoodRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230395212-A1 | Distributed system for logic-driven data routing | Inactive | 02-Jun-2022 | ||
| US-20210074401-A1 | Methods and systems to provide drug pricing information according to customer profile | Inactive | 03-Apr-2018 | ||
| US-10073951-B2 | Demographically filterable interface for conveying information about a medication | Inactive | 23-Jun-2014 | ||
| US-20150370998-A1 | Demographically filterable interface for conveying information about a medication | Active | 23-Jun-2014 | ||
| US-10552575-B1 | Medication monitoring and identification | Active | 07-Nov-2013 | G16H20/10 |
GoodRx Signals
GoodRx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GoodRx Investments & Acquisitions (10)
GoodRx’s most recent deal was a Merger/Acquisition with ScriptDrop for . The deal was made on 16-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ScriptDrop | 16-Oct-2025 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Vivid Clear Rx (VCRx Business in Omaha, Nebraska) | 13-Jan-2025 | Merger/Acquisition | Other Healthcare Services | ||
| VitaCare Prescription Services | 14-Apr-2022 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| flipMD | 18-Feb-2022 | Merger/Acquisition | Consulting Services (B2B) | ||
| RxSaver | 30-Apr-2021 | Merger/Acquisition | Media and Information Services (B2B) |
GoodRx ESG
Risk Overview
Risk Rating
Updated November, 08, 2026
25.41 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Software & Services
Industry
of 898
Rank
Percentile
Internet Software and Services
Subindustry
of 177
Rank
Percentile
GoodRx Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ScriptDrop | Columbus, OH | 2016 | |
| Scriptcycle | Asheville, NC | 2012 |
GoodRx FAQs
-
When was GoodRx founded?
GoodRx was founded in 2011.
-
Where is GoodRx headquartered?
GoodRx is headquartered in Santa Monica, CA.
-
What is the size of GoodRx?
GoodRx has 697 total employees.
-
What industry is GoodRx in?
GoodRx’s primary industry is Enterprise Systems (Healthcare).
-
Is GoodRx a private or public company?
GoodRx is a Public company.
-
What is GoodRx’s stock symbol?
The ticker symbol for GoodRx is GDRX.
-
What is the current stock price of GoodRx?
As of 12-Nov-2026 the stock price of GoodRx is $3.51.
-
What is the current market cap of GoodRx?
The current market capitalization of GoodRx is $1.2B.
-
What is GoodRx’s current revenue?
The trailing twelve month revenue for GoodRx is $785M.
-
Who are GoodRx’s competitors?
RxSense, mPharma, Blink Health, OptumRx, and Teladoc Health are some of the 7 competitors of GoodRx.
-
What is GoodRx’s annual earnings per share (EPS)?
GoodRx’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process